[Endolymphatic radionuclide therapy. Historical development and present status].
D000818:Animals; D001853:Bone Marrow / Q000528:radiation effects; D006049:Gold Isotopes / Q000008:administration & dosage / Q000627:therapeutic use; D006207:Half-Life; D007272:Injections, Intralymphatic; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use; D008168:Lung / Q000528:radiation effects; D008207:Lymphatic Metastasis / Q000532:radiotherapy*; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use; D011817:Rabbits; D011835:Radiation Protection; D011868:Radioisotopes / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D013324:Strontium / Q000008:administration & dosage / Q000627:therapeutic use; D013667:Technetium / Q000008:administration & dosage / Q000627:therapeutic use; D013961:Thyroid Gland / Q000528:radiation effects; D015020:Yttrium Isotopes / Q000008:administration & dosage / Q000627:therapeutic use
D006049:Gold Isotopes; D007457:Iodine Radioisotopes; D010761:Phosphorus Radioisotopes; D011868:Radioisotopes; D015020:Yttrium Isotopes; D013667:Technetium; D013324:Strontium
Endolymphatische Radionuklidtherapie. Historische Entwicklung und gegenwrtiger Stand.